Nanodroplets could speed up the search for new medicine

image via Phys.org - News and Articles on Science and Technology

August 21, 2025, 12:31 PM

• •KIT researchers developed a nanodroplet platform for drug discovery.
• •Platform uses miniaturized nanodroplets (200 nanoliters) for testing.
• •The platform integrates synthesis, testing, and characterization.
• •Researchers produced 325 MEK inhibitors in 7 days.
• •46 of the new inhibitors worked as well as mirdametinib in tests.

Researchers at the Karlsruhe Institute of Technology (KIT) have developed a groundbreaking nanodroplet platform for early-phase drug discovery, capable of testing thousands of therapeutic agents on a single chip. This innovative approach drastically reduces the time and resources required for drug development by using extremely miniaturized nanodroplets, each containing only 300 cells. The platform integrates synthesis, testing, and characterization, making high-throughput drug discovery more accessible to academic labs and smaller biotech companies. The researchers successfully synthesized and tested various potential MEK inhibitors, identifying 46 new compounds with similar efficacy to existing drugs, showcasing the platform's potential to accelerate the discovery of urgently needed new drugs.

Read original article